ERBB2 and breast cancer: By down regulating the expression of VEGF, it can inhibit the angiogenesis of breast cancer with high expression of HER-2/neu gene. The inhibition of angiogenesis is related to the inhibition of the signal transduction pathway of tylosin kinase membrane receptor tyrosine protein kinase (TPK)